DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 3076 - 3100 of 62743 in total
Disease ID ▼ Disease Name Gene Symbol Gene ID Gene Name UniProt ID
C2675526 Neutropenia, Severe Congenital, Autosomal Recessive 4 G6PC3 92579 glucose-6-phosphatase catalytic subunit 3 Q9BUM1
C2675496 Retinitis Pigmentosa 46 IDH3B 3420 isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta O43837
C2675491 AMYOTROPHIC LATERAL SCLEROSIS 11 FIG4 9896 FIG4 phosphoinositide 5-phosphatase Q92562
C2675487 Mental Retardation, Autosomal Dominant 4 ST3GAL4 6484 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 Q11206
C2675481 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 PIGU 128869 phosphatidylinositol glycan anchor biosynthesis class U Q9H490
C2675481 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 TMTC1 83857 transmembrane O-mannosyltransferase targeting cadherins 1 Q8IUR5
C2675481 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 CYP17A1 1586 cytochrome P450 family 17 subfamily A member 1 P05093
C2675481 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 ELOVL5 60481 ELOVL fatty acid elongase 5 Q9NYP7
C2675481 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 FADS2 9415 fatty acid desaturase 2 O95864
C2675481 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 CLEC3A 10143 C-type lectin domain family 3 member A O75596
C2675185 Kahrizi Syndrome SRD5A3 79644 steroid 5 alpha-reductase 3 Q9H8P0
C2674616 FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder) PLB1 151056 phospholipase B1 Q6P1J6
C2674616 FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder) PLA2G2A 5320 phospholipase A2 group IIA P14555
C2674616 FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder) MUTYH 4595 mutY DNA glycosylase Q9UIF7
C2674616 FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder) NTHL1 4913 nth like DNA glycosylase 1 P78549
C2674616 FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder) PTGS2 5743 prostaglandin-endoperoxide synthase 2 P35354
C2674218 SPHEROCYTOSIS, TYPE 1 (disorder) ACE 1636 angiotensin I converting enzyme P12821
C2674218 SPHEROCYTOSIS, TYPE 1 (disorder) CAT 847 catalase P04040
C2674218 SPHEROCYTOSIS, TYPE 1 (disorder) PTGS2 5743 prostaglandin-endoperoxide synthase 2 P35354
C2674173 Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans PLCG1 5335 phospholipase C gamma 1 P19174
C2673635 Combined Saposin Deficiency ASAH1 427 N-acylsphingosine amidohydrolase 1 Q13510
C2673635 Combined Saposin Deficiency PSAP 5660 prosaposin P07602
C2673477 Hypophosphatasia, Perinatal Lethal ALPL 249 alkaline phosphatase, biomineralization associated P05186
C2673377 MUCOLIPIDOSIS II ALPHA/BETA (disorder) GNPTAB 79158 N-acetylglucosamine-1-phosphate transferase subunits alpha and beta Q3T906
C2673377 MUCOLIPIDOSIS II ALPHA/BETA (disorder) NAGPA 51172 N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase Q9UK23

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024